Heterozigot β-talasemili kadınlarda gebelik değişkeninin HbA2 değeri üzerine etkisi

Kaynakça (8)

1. Özbolat G. Tuli A. Talasemi ve ilgili hemoglobinopatilerin Moleküler Tanı Yöntemleri: Günümüz ve Gelecek. Adıyaman Üni. Sağlık Bilimleri Derg, 2017;3(3):599-616
2. Paglietti ME, Satta S, Sollaino MC, Barella S, Ventrella A, Desogus MF, Demartis FR, Manunza L, Origa R. The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia. Acta Haematol. 2016;135(4):193-9
3. Özbolat G. Tuli A. Hematologic features of beta-globin gene mutation type (βo) with homozygous beta thalassemia. Ukr. Biochem. J., 2018, 90,4
4. Paglietti ME, Satta S, Sollaino MC, Barella S, Ventrella A, Desogus MF, Demartis FR, Manunza L, Origa R. The Problem of Borderline Hemoglobin A2 Levels in the Screening for β-Thalassemia Carriers in Sardinia. Acta Haematol. 2016;135(4):193-9
5. Menzel S, Garner C, Rooks H, Spector TD, Thein SL. HbA2 levels in normal adults are influenced by two distinct genetic mechanisms. Br J Haematol. 2013;160(1):101-5. 6. Șeicaru D. Constantinescu D. Corina F. Bulucea D. Heterozygous Beta-thalassemia, a Genetic Haemolytic Anaemia in Continuous Expansion. Acta Medica Marisiensis 2013;59(2):154-157
6. Kneifati-Hayek, J. Fleischman W. Bernstein LH. Riccioli A. Bellevue R. A model for automated screening of thalassemia in hematology (math study). Lab. Hematol., 2007;13, 119- 123
7. Giambona A, Passarello C, Renda D, Maggio A. The significance of the hemoglobin A(2) value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786-96
8. Özbolat G. Yılmaz N. Döğüş Y. Tuli A. The pregnancy variable in women with heterozygous beta thalassemia. Ejpmr, 2018,5(4), 98-100.